Vitamin D, a free sunshine vitamin available for mankind from nature, is capable to avert many health-related critical circumstances. Vitamin D is no more regarded as a nutrient involved in bone metabolism alone. The presence of vitamin D receptor in a number of tissues implies that vitamin D has various physiological roles apart from calcium and phosphorus metabolism. Low serum vitamin D has been found to be associated with various types of metabolic illness such as obesity, diabetes mellitus, insulin resistance, cardiovascular diseases including hypertension. Various studies reported that vitamin D insufficiency or deficiency in linked with metabolic syndrome risk. This review focuses on various metabolic diseases and its relationship with serum vitamin D status.
INTRODUCTION
Metabolic syndrome (MS) has become the most common health challenge worldwide, crossing the barriers of age, sex, and ethnicity. The risk factors associated with MS include hypertension, hyperlipidemia, hyperglycemia, insulin resistance with a strong association with abdominal obesity. Patients with MS have been at an increased risk of developing cardiovascular disease (CVD) and/or type 2 diabetes mellitus (T2DM) 1 , making it one of the leading causes of early death.
With two decades of research in this field, now various pathways involved in MS are explored and environmental, life style and genetical factors, either in single or combined forms, is responsible for the aggravation of the syndrome. 2 Many methods had been proposed in managing and preventing MS, which includes phytotherapy, metabolism intervening drug, diet therapy, physical exercise, hormonal therapy, chemotherapy, etc. Many reviews are available on MS; its prevention and treatment, however, there is still little knowledge on the role of vitamin D and its usefulness in combating MS. Accumulating data suggest that circulating serum vitamin D is inversely related to MS (Fig. 1 ). This review focuses on the impact of vitamin D on MS.
VITAMIN D AND OBESITY
Obesity can be defined as an abnormal or excessive accumula- Overall, poor vitamin D status could be positively associated with obesity, but the relationship between these variables has not Figure 1 . The cross-talk between retinoid X receptor (RXR), vitamin D receptor (VDR), and peroxisome proliferator-activated receptor (PPAR). VDR and PPAR share a common binding partner RXR and a common binding site in the DNA, steroid and nuclear hormone receptor binding site. Hence the dominance of expression will be dependent on the availability ratio of VDR and PPAR; both have to compete with one another to get engaged with RXR so that they could get inside the nucleus and could bind at their site of interest. If PPAR concentration is higher than the gene expression of its governance will be dominating the cell, if VDR is higher than the genome will be more accessible for it rather than for PPARs. LVH, left ventricular hypertrophy; CVD, cardiovascular disease. been precisely determined. The possible reason could be that obese individuals have insufficient sun exposure and outdoor activities. 13 Additionally, vitamin D receptor (VDR) expression in adipose tissue, food intake and exercise levels also seem to be associated to the vitamin D deficiency in obesity.
14,15 MMTV integration site/β-catenin pathway which is implicated in various cellular functions and processes 21 and it is a negative regulator of adipogenesis. 22 Studies on other types of cell lines also concluded same type of results (Table 1) . 20, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] Mesenchymal cells collected from murine bone marrow when cultured in induction media along with 18 × 10 −12 mol/L of vitamin D showed poor differentiation of bone marrow derived cells into adipocytes.
VITAMIN D AND ADIPOCYTE
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VITAMIN D AND THERMOGENESIS
Thermogenesis, the process of heat generation is an essential mechanism in keeping constant body temperature when the surrounding temperature starts dropping. In terms of obesity management thermogenesis is taken as a way for reducing stored fat by subjecting them to β-oxidation that results in the production of adenosine triphosphate as well as heat. In a human study, body weight and fat mass were decreased by low energy diet and vitamin D supplementation 34, 35 and in mice model, vitamin D protected the mice 33 Murine bone marrow stromal cell (BMS2) Inhibited adipocyte differentiation: decreased late adipocyte gene markers, Ap2 and adipsin from diet induced obesity due to increased adipose tissue apoptosis. 36 Furthermore, thermogenesis and fat oxidation rates in subsequent meals were significantly increased through vitamin D-rich breakfast intake, suggesting a direct link to metabolism. 37 
VITAMIN D AND ATHEROSCLEROSIS
Atherosclerosis is the buildup of cholesterol-rich lipids on the arterial wall accompanied with inflammatory responses. 39 mellitus have heart disease than white patients and lower calcified atherosclerotic plaques are associated with a lower risk of heart disease in blacks. However, high vitamin D intake accelerates vascular calcification in animal model. 42 This study reported that when rodents were fed with high cholesterol diets along with high dose of vitamin D2 (300,000 IU/kg body weight/day) up to 4 weeks, accelerated calcified plaque formation in the arteries 43 was observed, indicating that both excess and deficiency are detrimental.
VITAMIN D AND HYPERTENSION
Vitamin D deficiency and insufficiency have been observed to upregulate the renin-angiotensin-aldosterone system (RAAS), resulting in hypertension. Studies found that both the systolic and diastolic blood pressure are decreased by administering vitamin D in older adults with existing high blood pressure. There is direct link between vitamin D and renin angiotensin system (RAS) as vitamin D acts as a potent endocrine suppressor in renin biosynthesis through regulation of the RAS. 44 In a double-blind study, 400 IU of vitamin D3 with 1,000 mg of elemental calcium daily, or placebo were given to 36,282 postmenopausal women, it was observed that the blood pressure changed along with the incidence of hypertension. There was no clinically meaningful effects in systolic blood pressure and diastolic blood pressure between the treatment and comparison groups for a median follow-up time of 7 years. 45 However, in another study by Judd et al. 46 , nine subjects were categorized into three groups, either placebo, vitamin D3 or vitamin D2. Dose of 200,000 IU vitamin D3 (n = 3) or matching placebo (n = 3) given orally to the individuals weekly, or 0.5 μg calcitriol (n = 2) was taken twice every day for 3 weeks. It was observed intake of calcitriol lowered the systolic blood pressure by 9% when compared to the placebo. However after the period of conclusion the systolic blood pressure returned to pretreatment levels 1 week 
VITAMIN D AND CVD
CVD always finds company with metabolic diseases. Recent research highlighted the importance of vitamin D deficiency in several CVD conditions. Vitamin D deficiency has been positively correlated with poor cardiac contractility 48 , increased myocardial collagen content 49 , and cardiac tissue maturation. 50 VDRs have a broad tissue distribution that includes vascular smooth muscle, endothelium, and cardiomyocytes. 51 It has been well documented that the occurrence of CVD related mortality has a strong association with environmental factors such as geographic latitude, altitude, season, and the place of residence (urban or rural).
52-54
Interestingly, all these factors have a strong relationship with the UVB exposure and therefore the serum vitamin D level. 55 There- , and other beneficial effects on cardiovascular risk factors. 62 Wang et al. 56 did a study on 1,739 subjects (mean age, 59
years; 55% women; all white) without previous CVD history.
Their serum vitamin D level was assessed marked deficiency if found below <15 ng/mL and <10 ng/mL. Near about 28% of the subjects showed vitamin D status <15 ng/mL and about 9% had 
VITAMIN D AND INSULIN RESISTANCE AND DIABETES MELLITUS
The insulin deregulation and diabetes mellitus go hand in hand.
People with increase BMI in younger age suffers from diabetic complication in middle age. Insulin resistance is the most common cause for non-insulin dependent diabetic mellitus (NIDDM). Insulin resistance increases the risk for other disease in an individual.
People with insulin resistance are more prone to suffer with NID-
, CVD [67] [68] [69] and kidney disease. 70, 71 Accumulating evidence suggests that decrease in insulin secretion in both humans as well as animal models has a strong correlation with vitamin D deficiency. 72 It has been reported by several studies that the lower level of vitamin D triggers the development of insulin resistance and thus NIDDM by deregulating the insulin sensitivity or β-cell function, or both. [72] [73] [74] [75] A two decade old report by Taylor 
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